Americord Registry

Supervises the collection, processing and storage of umbilical cord blood, cord tissue and placenta tissue from newborn babies in case it is needed for future medical treatments.

2018 Inc. 5000 Rank:
# 1603
Leadership:
Martin Smithmyer
2017 Revenue:
$ 7.6 M
3-Year Growth:
290%
Industry:
Health
Location:
New York City NY 
Founded:
2008

Previous Inc. 5000 Rankings 

2017
#2739
2016
#3092
2015
#286

MORE COMPANY INFORMATION

What is this?

Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. For more information, visit www.americordblood.com.

—Information provided by company
Twitter:
@Americord
Inc. Verified Profiles are not endorsements of the listed products or services. See what Inc.’s verification entails at www.inc.com/verified